Skip to Main Content

++

INTRODUCTION

++

Antidysrhythmic agents, which are also known as antiarrhythmic agents, are a broad category of medications that help ameliorate the spectrum of cardiac arrhythmias to maintain normal rhythm and conduction in the heart. Arrhythmias generally arise as a result of abnormal impulse generation or abnormal conduction, or a combination of the two. Abnormal impulse generation falls into one of two categories: abnormal automaticity or triggered activity. Abnormal automaticity is thought to occur due to reduced resting membrane potential, causing the membrane to be closer to the threshold for generating an action potential. Triggered activity, or after-depolarization, occurs during the early stages after depolarization, such as in phase 2 and 3, or in the later stage during phase 4. With either form, it requires a preceding triggering beat to create the abnormal depolarization. Abnormal conduction is usually due to conduction block or a reentry phenomenon, with the latter being the most common cause of dysrhythmias. Antidysrhythmics exert their effect on specific ion channels on the cardiac cell membrane which then alters the shape of the action potential, and thus have inotropic, chronotropic, and toxic actions as a result.

++

CLASSIFICATION

++

The most common classification system for antidysrhythmic agents is the Harrison modification of Vaughan Williams (Table 166-1). This system classifies each agent based upon its unique electrophysiologic and pharmacological properties. Vaughan Williams classification divides these agents in one of four groups, Class I, II, III, and IV. There is a further subdivision of Class I agents, the so-called sodium channel blockers, into IA, IB, and IC.

++
Table Graphic Jump Location
TABLE 166-1   Classification of Antidysrhythmic Agents 
++

  • Class I agents block the rapid inward sodium channel, slow the rate of rise of phase 0, and so decrease the rate of depolarization. The subgrouping of Class I agents allows for differentiating their electrophysiologic effects. Class IA drugs (quinidine, procainamide, and disopyramide) prolong the repolarization and the refractoriness of isolated myocardial tissue as well as block the inward sodium current. They also have potassium channel blocking properties, and so increase action potential duration and the effective refractory period. Class IB drugs (lidocaine, tocainide, and mexiletine) produce only modest inhibition of the rapid inward sodium current and so shorten the refractory period, and reduce the ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessAnesthesiology Full Site: One-Year Subscription

Connect to the full suite of AccessAnesthesiology content and resources including procedural videos, interactive self-assessment, real-life cases, 20+ textbooks, and more

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessAnesthesiology

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.